🔬 Ms. Falguni Goel is a dedicated researcher and Assistant Professor at MIET, Meerut, specializing in neuropharmacology and molecular biotechnology. With a passion for understanding neuropsychiatric disorders like Huntington’s and Parkinson’s, she brings innovation through herbal drug discovery and advanced lab techniques. 🧠 She holds multiple patents, has published in high-impact journals 📚, and excels in zebrafish-based research. 🎯 Falguni’s goal is to blend science, creativity, and compassion to make breakthroughs in neurotherapeutics. 💡
Profile
Scopus Profile
Orcid profile
Google Scholar Profile
🎓 Early Academic Pursuits
Falguni Goel, has demonstrated exceptional commitment to science from an early age. Her academic journey began with a passion for biology and evolved into a specialized interest in neuropharmacology and molecular biotechnology. With a solid foundation laid during her M.Pharm studies, she completed a compelling thesis titled “Protective Effect of Diacerein in Quinolinic Acid Induced Huntington’s Like Symptoms in Adult Zebrafish Targeting GSK-3β Signalling”, showcasing her early focus on neurodegenerative research. 🧬📘
💼 Professional Endeavors
Currently serving as an Assistant Professor at MIET, Meerut, Falguni blends academic leadership with active research. She is also an enthusiastic educator and mentor, committed to shaping the next generation of pharmaceutical and neuroscience researchers. Her drive for innovation is deeply tied to her academic and professional goals. 🎓📚
🔬 Contributions and Research Focus On Neuropharmacology
Falguni’s research is sharply focused on neuropsychiatric disorders, particularly Huntington’s, Parkinson’s, Dementia, Autism, and depression. She explores molecular pathways, diagnostic markers, and behavioral models in zebrafish and rodents to understand these conditions. Her work emphasizes drug development using both synthetic and herbal phytochemicals, aiming to bridge traditional and modern approaches in neuroscience. 🧪🧠🌿
🌍 Impact and Influence
Her impactful research is evident in numerous high-impact publications and national patents. Her findings have not only advanced understanding of neurological disorders but also introduced new experimental methodologies and apparatus for behavioral studies. She has set benchmarks, particularly in zebrafish brain studies and drug delivery techniques. 🏅💡
🧠 Research Skills
Falguni is skilled in a wide array of research techniques:
-
Zebrafish and rodent behavioral modeling 🐟🐀
-
Brain dissection, histopathology, and drug delivery via multiple routes 🧠💉
-
Molecular techniques including Western Blot, PCR, ELISA, HPLC, and cryo-sectioning 🧫🔬
-
Biochemical analysis of neurotransmitters and signaling proteins 🧬🧪
-
Expertise in behavioral software (AnyMaze), data analysis tools (GraphPad Prism), and manuscript writing 📊📝
She is known for pioneering i.c.v. administration in zebrafish in India and innovating several research apparatuses enhancing experimental reliability.
🏅 Awards and Honors
Falguni’s scholarly achievements have earned her numerous accolades, including multiple granted patents by the Government of India. Her innovations in experimental neuroscience are widely recognized, including devices such as the Zebrafish Behavioral Exploration Apparatus and Electro-convulsiometer Ring for Rodents. Her early participation in the national platform Pariksha pe Charcha with Prime Minister Modi also reflects her active civic engagement. 🥇📜
🏛️ Legacy and Future Contributions
With over a dozen patents and 20+ publications already under her name at just 23, Falguni Goel’s legacy is only beginning. She envisions pioneering more AI-integrated health solutions and developing innovative tools to advance neuropharmacology. Her dedication promises substantial contributions to neuroscience, both academically and clinically, in the coming decades. 🚀🧠🧑🔬
Publications Top Notes
📄 Apigenin protects melanocytes and improve tyrosinase activity in a hydroquinone induced vitiligo mouse model targeting P38 MAP kinase signaling: histopathology and …
📚 Naunyn-Schmiedeberg’s Archives of Pharmacology
🗓️ 2024
🧠 Protective effects of diacerein against quinolinic acid–induced Huntington’s disease–like symptoms in adult zebrafish by targeting GSK-3β signalling
📚 Naunyn-Schmiedeberg’s Archives of Pharmacology
🗓️ 2025
🧬 Beyond dopamine: novel therapeutic pathways for Parkinson’s disease through receptor signaling
📚 CNS & Neurological Disorders – Drug Targets
🗓️ 2025
🧩 From Genetics to Function: the Role of ABCA12 in Autism Neurobiology
📚 Journal of Molecular Neuroscience
🗓️ 2025
🤖 The Future of Drug Development: Leveraging AI for Faster and Safer Innovation
📚 Journal of Advanced Scientific Research
🗓️ 2025